Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Stuart Iain Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 1,184 shares @ $3.83, valued at $4.5k
07/05/2023 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 151 shares @ $4.1, valued at $619.1
04/04/2023 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 480 shares @ $3.08, valued at $1.5k
01/04/2023 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 1,720 shares @ $0.15, valued at $258
10/04/2022 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 1,719 shares @ $0.223, valued at $383.3
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 3,469 shares @ $0.65, valued at $2.3k
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/08/2020 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Granted 112,500 shares @ $0
Granted 112,500 options @ $1.95, valued at $219.4k
04/07/2020 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Granted 27,530 shares @ $0
Granted 97,682 shares @ $0
Paid exercise price by delivering 3,763 shares @ $1.4, valued at $5.3k
04/02/2020 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Paid exercise price by delivering 1,940 shares @ $2.68, valued at $5.2k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/11/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2019 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Sold 951 shares @ $2.35, valued at $2.2k
04/03/2019 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Sold 1,696 shares @ $3.75, valued at $6.4k
01/03/2019 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 32,569 shares @ $0
Granted 75,997 options to buy @ $3.77, valued at $286.5k
11/13/2018 4 Stuart Iain (SVP R&D) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Sold 683 shares @ $4.58, valued at $3.1k
08/09/2018 4 Stuart Iain (SVP R&D) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Sold 2,715 shares @ $5.68, valued at $15.4k
02/28/2018 4 Stuart Iain (SVP R&D) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 10,000 shares @ $0
Granted 30,000 options to buy @ $6.35, valued at $190.5k
01/11/2018 3 Stuart Iain (SVP R&D) has filed a Form 3 on Foamix Pharmaceuticals Ltd.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy